A net cash position is a rarity for large pharmaceutical companies, but these two may have exceptional financial flexibility because of it.
A North Carolina court has temporarily blocked a state law passed by the GOP-controlled legislature that strips the Democratic governor of his some of his powers.
Falling sales mixed with disappointing guidance sends shares in a tailspin.
But that might not be the worst thing about Snap's capital structure.
The commercial-property financing specialist continued to take advantage of favorable conditions in the real estate market.
The company says it won't be building a robot-run supermarket, but it does have brick-and-mortar plans.
New sales guidance for Gilead Sciences suggests that the company's struggles could continue to disappoint investors this year.
The dry-bulk carrier reported progress in several key areas but missed on one crucial factor.
The Danish government on Wednesday teamed up with the former head of drug company Novo Nordisk in its campaign to become the new host of the London-based European Medicines Agency (EMA) after Britain's vote to leave the European Union.
President Trump on Wednesday brought the legal dispute over his immigration executive order into the court of public opinion, using a Washington law enforcement address to mount an urgent defense of the measure and urge the federal courts to reinstate it.